These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23849058)

  • 1. Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine.
    Xue L; Hou S; Tong M; Fang L; Chen X; Jin Z; Tai HH; Zheng F; Zhan CG
    Biochem J; 2013 Aug; 453(3):447-54. PubMed ID: 23849058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
    Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
    Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
    Yang W; Xue L; Fang L; Chen X; Zhan CG
    Chem Biol Interact; 2010 Sep; 187(1-3):148-52. PubMed ID: 20060817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.
    Zhan M; Hou S; Zhan CG; Zheng F
    Biochem J; 2014 Jan; 457(1):197-206. PubMed ID: 24125115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
    Hou S; Xue L; Yang W; Fang L; Zheng F; Zhan CG
    Org Biomol Chem; 2013 Nov; 11(43):7477-85. PubMed ID: 24077614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.
    Xue L; Ko MC; Tong M; Yang W; Hou S; Fang L; Liu J; Zheng F; Woods JH; Tai HH; Zhan CG
    Mol Pharmacol; 2011 Feb; 79(2):290-7. PubMed ID: 20971807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational redesign of human butyrylcholinesterase for anticocaine medication.
    Pan Y; Gao D; Yang W; Cho H; Yang G; Tai HH; Zhan CG
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16656-61. PubMed ID: 16275916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a cocaine hydrolase engineered from human butyrylcholinesterase on metabolic profile of cocaine in rats.
    Chen X; Zheng X; Zhou Z; Zhan CG; Zheng F
    Chem Biol Interact; 2016 Nov; 259(Pt B):104-109. PubMed ID: 27154495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of an enzyme mutant for anti-cocaine therapeutics.
    Zheng F; Zhan CG
    J Comput Aided Mol Des; 2008 Sep; 22(9):661-71. PubMed ID: 17989928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
    Duysen EG; Bartels CF; Lockridge O
    J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.
    Fang L; Hou S; Xue L; Zheng F; Zhan CG
    Chem Biol Interact; 2014 May; 214():18-25. PubMed ID: 24582612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.
    Hamza A; Cho H; Tai HH; Zhan CG
    J Phys Chem B; 2005 Mar; 109(10):4776-82. PubMed ID: 16851561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene.
    Hou S; Zhan M; Zheng X; Zhan CG; Zheng F
    Biochem J; 2014 Jun; 460(3):447-57. PubMed ID: 24870023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression.
    Chen X; Deng J; Zheng X; Zhang J; Zhou Z; Wei H; Zhan CG; Zheng F
    Chem Biol Interact; 2019 Jun; 306():89-95. PubMed ID: 30986387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.
    Xie W; Altamirano CV; Bartels CF; Speirs RJ; Cashman JR; Lockridge O
    Mol Pharmacol; 1999 Jan; 55(1):83-91. PubMed ID: 9882701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-engineering butyrylcholinesterase as a cocaine hydrolase.
    Sun H; Pang YP; Lockridge O; Brimijoin S
    Mol Pharmacol; 2002 Aug; 62(2):220-4. PubMed ID: 12130672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic activities of cocaine hydrolases against the most toxic cocaine metabolite norcocaethylene.
    Zheng X; Chen X; Zhang T; Zhan M; Zhan CG; Zheng F
    Org Biomol Chem; 2020 Mar; 18(10):1968-1977. PubMed ID: 32101217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most efficient cocaine hydrolase designed by virtual screening of transition states.
    Zheng F; Yang W; Ko MC; Liu J; Cho H; Gao D; Tong M; Tai HH; Woods JH; Zhan CG
    J Am Chem Soc; 2008 Sep; 130(36):12148-55. PubMed ID: 18710224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free energy perturbation simulation on transition states and high-activity mutants of human butyrylcholinesterase for (-)-cocaine hydrolysis.
    Yang W; Pan Y; Fang L; Gao D; Zheng F; Zhan CG
    J Phys Chem B; 2010 Aug; 114(33):10889-96. PubMed ID: 20677742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.
    Brimijoin S; Gao Y; Anker JJ; Gliddon LA; Lafleur D; Shah R; Zhao Q; Singh M; Carroll ME
    Neuropsychopharmacology; 2008 Oct; 33(11):2715-25. PubMed ID: 18199998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.